Clinical Trial Update: A Clinical Research of CD33-Targeted CAR-T in Myeloid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a CD33-targeted CAR-T therapy in myeloid malignancies (Phase 1/Phase 2) with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloid Malignancies

Drugs mentioned

• CD33-targeted CAR-T (CD33-targeted chimeric antigen receptor T-cell therapy)

Snippet

Sponsor: Southwest Hospital, China | Conditions: Myeloid Malignancies | Phase 1, Phase 2 | Status: UNKNOWN